CO2017005389A2 - Subunit, polyvalent highly immunogenic vaccine against mastitis in mammals - Google Patents

Subunit, polyvalent highly immunogenic vaccine against mastitis in mammals

Info

Publication number
CO2017005389A2
CO2017005389A2 CONC2017/0005389A CO2017005389A CO2017005389A2 CO 2017005389 A2 CO2017005389 A2 CO 2017005389A2 CO 2017005389 A CO2017005389 A CO 2017005389A CO 2017005389 A2 CO2017005389 A2 CO 2017005389A2
Authority
CO
Colombia
Prior art keywords
polyvalent
mammals
vaccine against
highly immunogenic
subunit
Prior art date
Application number
CONC2017/0005389A
Other languages
Spanish (es)
Inventor
Acevedo Lisette Nicole Lapierre
Iturriaga Leonardo Enrique Sáenz
Original Assignee
Univ Chile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Chile filed Critical Univ Chile
Publication of CO2017005389A2 publication Critical patent/CO2017005389A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Vacuna subunitaria, polivalente altamente inmunogénica contra mastitis en mamíferos, de una formulación que comprende mezcla de fragmentos de pared y membranas celular y pequeños liposomas originados desde la membrana celular de los patógenos seleccionados de Staphylococcus aureus, Escherichia coli y Streptococcus uberis, donde dichos fragmentos de pared celular y membranas liberan elementos intracelulares inmunoestimulantes tales como proteínas de membrana, lipopolisacárido, peptidoglicano, exo.Highly immunogenic, polyvalent subunit vaccine against mastitis in mammals, of a formulation comprising a mixture of cell wall and membrane fragments and small liposomes originating from the cell membrane of the selected pathogens of Staphylococcus aureus, Escherichia coli and Streptococcus uberis, where said fragments of Cell wall and membranes release immunostimulating intracellular elements such as membrane proteins, lipopolysaccharide, peptidoglycan, exo.

CONC2017/0005389A 2014-11-28 2017-05-26 Subunit, polyvalent highly immunogenic vaccine against mastitis in mammals CO2017005389A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CL2014003247A CL2014003247A1 (en) 2014-11-28 2014-11-28 Subunit vaccine, polyvalent against mastitis in mammals, comprising cell wall and membrane fragments of pathogens selected from staphylococcus aureus, escherichia coli and streptococcus uberis; preparation procedure; and use to immunogenize a mammal.
PCT/CL2015/050046 WO2016082054A1 (en) 2014-11-28 2015-11-25 Polyvalent, highly immunogenic subunit vaccine against mastitis in mammals

Publications (1)

Publication Number Publication Date
CO2017005389A2 true CO2017005389A2 (en) 2017-07-19

Family

ID=56073267

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2017/0005389A CO2017005389A2 (en) 2014-11-28 2017-05-26 Subunit, polyvalent highly immunogenic vaccine against mastitis in mammals

Country Status (5)

Country Link
BR (1) BR112017011292B1 (en)
CL (1) CL2014003247A1 (en)
CO (1) CO2017005389A2 (en)
MX (1) MX2017006892A (en)
WO (1) WO2016082054A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024072985A1 (en) * 2022-09-28 2024-04-04 University Of Tennessee Research Foundation Polyvalent vaccines for staphylococcal & streptococcal infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011018858A1 (en) * 2009-08-14 2011-02-17 エヌエーアイ株式会社 Novel mastitis vaccine

Also Published As

Publication number Publication date
BR112017011292A2 (en) 2017-12-26
MX2017006892A (en) 2018-01-23
WO2016082054A9 (en) 2016-06-23
BR112017011292B1 (en) 2024-01-16
CL2014003247A1 (en) 2015-07-10
WO2016082054A1 (en) 2016-06-02

Similar Documents

Publication Publication Date Title
AR101225A1 (en) MENINGOCOCK VACCINES
WO2016019134A8 (en) Flagellin-based agents and uses including effective vaccination
EA201892568A1 (en) METHODS OF OBTAINING CONTRAST FACILITIES FOR ULTRASONIC RESEARCH
EP3411430A4 (en) Bipolar ionomer membrane
EP3494193A4 (en) Crosslinking of hydroxide stable, polybenzimidazoliums and polyimidazoliums membranes and ionomers
BR112016018654A2 (en) STABILIZED SILICATE COMPOSITIONS AND THEIR USE AS ANTIPERSPIRANT COMPOSITIONS
MX2016014564A (en) Vaccine against acinetobacter baumannii based on cellular components deficient in lipopolysaccharide.
IL266080B (en) Expec glycoconjugate vaccine formulations
EP3528931A4 (en) Osmotic membrane
MY191539A (en) Streptococcal vaccine
BR112018013932A2 (en) platelet preparation systems and methods
CL2015001446A1 (en) Preparation procedure of human albumin with reduced dissolved oxygen level.
CL2018000513A1 (en) Pestivirus vaccines for congenital tremors
DOP2018000209A (en) ALFAVIRUS CONSTRUCTOS ATENUADO VIVO AND METHODS AND USES OF THE SAME
CO2017005389A2 (en) Subunit, polyvalent highly immunogenic vaccine against mastitis in mammals
EP3439693A4 (en) Novel pneumococcal vaccine formulations
PE20190225A1 (en) A METHOD TO REDUCE EGG CONTAMINATION
EP3903810A4 (en) Preparation including vaccine adjuvant
EA201991319A1 (en) VACCINES OF ATTENUATED SWINE INFLUENZA AND METHODS OF THEIR MANUFACTURE AND APPLICATION
WO2015149085A8 (en) Water-soluble trans-membrane proteins and methods for the preparation and use thereof
WO2015071769A3 (en) Outer membrane vesicles and uses thereof
EP3529260A4 (en) Vaccine constructs and uses thereof against staphylococcus infections
Synnes Research on Differing Attitudes Towards Interim Management as an Employment Form among Different Cultures
媛媛 Maya the Bee Movie
李晓涵 Brainy Is the New Sexy——“The Physicist Behind The Big Bang Theory’s Nerd Cred”